35812 Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices 

described in FDA’s March 2020 

Enforcement Policy for Ventilators 

and Accessories and Other 

Respiratory Devices During the 

Coronavirus Disease 2019 (COVID– 

19) Public Health Emergency 

located at https://www.fda.gov/ 

media/136318/ download. 

17. Alcohol-based (over 60 percent) 

hand sanitizer and rubs. 

Notice of Designation of Scarce 

Materials or Threatened Materials 

Health or medical resources, or any of 

their essential components, determined 

by the Secretary of HHS to be needed to 

respond to the spread of COVID–19 and 

which are, or are likely to be, in short 

supply (scarce materials) or the supply 

of which would be threatened by 

hoarding (threatened materials). 

Designated scarce materials or 

threatened materials are subject to 

periodic review by the Secretary. 

The following materials are 

designated, pursuant to section 102 of 

the Defense Production Act (50 U.S.C. 

4512) and Executive Order 13190 of 

March 23, 2020 (Preventing Hoarding of 

Health and Medical Resources to 

Respond to the Spread of COVID–19), as 

scarce materials or threatened materials: 

1. Medical gowns or apparel, e.g., 

surgical gowns or isolation gowns 

2. Laboratory reagents and materials 

used for isolation of viral genetic 

material and testing, such as transport 

media, collection swabs, test kits and 

reagents specific to those kits, and 

consumables such as plastic pipette tips 

and plastic tubes 

3. Drug products currently 

recommended by the National Institutes 

of Health COVID–19 Treatment 

Guidelines Panel, including (as of April 

21, 2021) remdesivir and 

dexamethasone 

4. Syringes and hypodermic needles 

(whether distributed separately or 

attached together) generally used in the 

United States for vaccinations that are 

either: 

(i) Piston syringes in 1 ml or 3 ml 

sizes that allow for the controlled and 

precise flow of liquid as described by 21 

CFR 880.5860, that are compliant with 

ISO 7886–1:2017 and use only Current 

Good Manufacturing Practices (CGMP) 

processes; or 

(ii) Hypodermic single lumen needles 

between 1’’ and 1.5’’ and 22 to 25 gauge 

between 1’’ and 1.5’’ and 22 to 25 gauge 

that have engineered sharps injury 

protections as described in the 

Needlestick Safety and Prevention Act, 

Public Law 106–430, 114 Stat. 1901 

(Nov. 6, 2000) and OSHA standard 29 

CFR 1910.1030, Bloodborne Pathogens.’’ 

Authority: The authority for this Notice is 

Executive Order 13910 and section 102 of the 

Defense Production Act of 1950, 50 U.S.C. 

4512, as amended. 

Dated: June 30, 2021. 

Xavier Becerra 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2021–14383 Filed 7–2–21; 4:15 pm] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–4040–0001] 

Agency Information Collection 

Request: 60-Day Public Comment 

Request 

AGENCY: Office of the Secretary, Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before September 7, 

2021. 

ADDRESSES: Submit your comments 

sagal.musa@hhs.gov or by calling (202) 

205–2634. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 4040–0001– 

Revision–60D and project title for 

reference, to Sagal Musa, email: 

sagal.musa@hhs.gov, or call (202) 205– 

2634 the Reports Clearance Officer. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: SBIR/STTR 

Information. 

Type of Collection: Revision of A 

Currently Approved Collection. 

OMB No.: 4040–0001. 

Abstract: The SBIR (Small Business 

Innovation Research)/STTR (Small 

Business Technology Transfer) program 

is designed to stimulate technological 

innovation in the private sector by 

strengthening the role of small business, 

increasing the commercial application 

of federally supported research results, 

as well as fostering and encouraging 

participation by socially and 

economically disadvantaged and 

women-owned small businesses. This 

form is used by grant applicants to 

apply for SBIR/STTR-related grants. 

Grants.gov seeks to include a question 

regarding the use of SBIR/STTR funds 

for Technical and Business Assistance 

(TABA). 

ANNUALIZED BURDEN HOUR TABLE

Forms 

(If necessary) 

Respondents 

(If necessary) 

Number of 

respondents 

Number of 

responses per 

respondents 

Average 

burden per 

response 

Total 

burden hours 

SBIR/STTR Information .................... Grant Applicants ............................... 6,376 1 1 6,376 

Total ........................................... ........................................................... 6,376 1 1 6,376 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 127 / Wednesday, July 7, 2021 / Notices 35813 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–14436 Filed 7–6–21; 8:45 am] 

BILLING CODE 4151–AE–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Charter Renewal 

In accordance with Title 42 of the 

U.S. Code of Federal Regulations, 

Section 217a, notice is hereby given that 

the Charter for the Sickle Cell Diseases 

Advisory Committee was renewed for 

an additional two-year period on June 

30, 2021. 

It is determined that the Sickle Cell 

Diseases Advisory Committee is in the 

public interest in connection with the 

performance of duties imposed on the 

National Institutes of Health by law, and 

that these duties can best be performed 

through the advice and counsel of this 

group. 

Inquiries may be directed to Claire 

Harris, Director, Office of Federal 

Advisory. Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail Stop Code 4875), Telephone (301) 

496–2123, or harriscl@mail.nih.gov. 

Dated: June 30, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14420 Filed 7–6–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

NHLBI Conference Grants. 

Date: August 4, 2021. 

Time: 12:30 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6705 

Rockledge Drive, Bethesda, MD 20817 

(Virtual Meeting). 

Contact Person: Michael P. Reilly, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6705 Rockledge Drive, Room 208–Z, 

Bethesda, MD 20892, (301) 827–7975, 

reillymp@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: June 30, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14421 Filed 7–6–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director Notice of Charter 

Renewal 

In accordance with Title 42 of the 

U.S. Code of Federal Regulations, 

Section 217a, notice is hereby given that 

the Charter for the Novel and 

Exceptional Technology and Research 

Advisory Committee was renewed for 

an additional two-year period on June 

30, 2021. 

It is determined that the Novel and 

Exceptional Technology and Research 

Advisory Committee is in the public 

interest in connection with the 

performance of duties imposed on the 

National Institutes of Health by law, and 

that these duties can best be performed 

through the advice and counsel of this 

group. 

Inquiries may be directed to Claire 

Harris, Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail Stop Code 4875), Telephone (301) 

496–2123, or harriscl@mail.nih.gov. 

Dated: June 30, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14368 Filed 7–6–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Myalgic 

Encephalomyelitis/Chronic Fatigue 

Syndrome. 

Date: July 30, 2021. 

Time: 11:30 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: M. Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1766, bennettc3@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–21– 

089 SPF Macaque Colonies. 

Date: August 6, 2021. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Shiv A. Prasad, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5220, 

MSC 7852, Bethesda, MD 20892, 301–443– 

5779, prasads@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES